Natco Pharma Ltd has launched a generic version of Tamiflu oral capsules in the US.
This is the first generic equivalent of Tamiflu capsules, the company said in a regulatory filing to the stock exchange on Monday. The company has launched the product, an antiviral medicine used in the treatment of influenza, through its marketing partner Alvogen.
A US registered trademark of Hoffman La-Roche Inc. Corporation, Tamiflu capsules had US sales of around $ 403 million during the 12 months ended December 2015, the Hyderabad-based firm said citing IMS Health figures.
